Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
36
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lu Timothy K | CEO, Director | 10 | $0 | $18.3K | 2026-10-21 |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Off. | 15 | $0 | $6.1K | 2026-10-21 |
| Baum Bryan Daniel | Director | 1 | $0 | $0 | 2025-07-18 |
| Hsiung Feng | Director | 2 | $0 | $0 | 2025-06-25 |
| Schulz Fran | Director | 3 | $0 | $0 | 2025-06-25 |
| COOPERSTONE BRENDA | Director | 5 | $0 | $0 | 2025-06-25 |
| Tang Donald F | Director | 3 | $0 | $0 | 2025-06-25 |
| Collins James J. | Director | 5 | $0 | $0 | 2025-06-25 |
| Mathers Edward T | Director | 5 | $0 | $0 | 2025-06-25 |
| Celadon Partners SPV 24 | 10% Owner | 2 | $0 | $0 | 2025-03-10 |
| Bayer US Holding LP | 10% Owner | 4 | $0 | $0 | 2025-03-10 |
| Florence Anthony A. Jr. | 10% Owner | 2 | $0 | $0 | 2025-03-10 |
| Cross John Harry III | Chief Financial Officer | 1 | $0 | $0 | 2025-03-07 |
| Farokhzad Omid | Director | 7 | $0 | $0 | 2024-07-10 |
| KNOBELMAN DEBORAH | Chief Financial Officer | 5 | $0 | $0 | 2024-02-01 |
| Berland Susan D | Director | 2 | $0 | $0 | 2023-06-16 |
| Lee Philip J | Chief Technology Officer | 1 | $0 | $0 | 2023-02-01 |
| Epstein David R | Director | 3 | $0 | $0 | 2022-07-13 |
| Dynamics Sponsor LLC | Director, 10% Owner | 3 | $0 | $0 | 2022-06-08 |
| MARTELL RON | Chief Executive Officer | 1 | $0 | $0 | 2014-06-25 |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | 8 | $0 | $0 | 2014-06-13 |
| SMIDER VAUGHN | See Remarks | 16 | $0 | $0 | 2014-06-13 |
| Frost Gamma Investments Trust | Director, 10% Owner | 10 | $0 | $0 | 2014-06-13 |
| RIOS MIGUEL DE LOS | VP- Research | 1 | $0 | $0 | 2014-05-16 |
| Isabelle Warren John | Director | 2 | $0 | $0 | 2014-05-16 |
| Van Hulst Jack | Director | 5 | $0 | $0 | 2014-05-16 |
| QUICK THOMAS C | Director | 5 | $0 | $0 | 2014-05-16 |
| STALDER RUEDI | Director | 5 | $0 | $0 | 2014-05-16 |
| Waksal Harlan | Director | 5 | $0 | $0 | 2014-05-14 |
| BRACA JOHN N | Director | 4 | $0 | $0 | 2014-05-14 |
| RECTOR DAVID | Director | 4 | $0 | $0 | 2014-05-14 |
| FORBES CHRISTOPHER | Director, 10% Owner | 4 | $0 | $0 | 2014-05-14 |
| Browne Leslie J | President and CEO | 3 | $4.5K | $0 | 2013-12-19 |
| Dondero Richard S | VP Research | 1 | $0 | $0 | 2013-09-13 |
| THOMPSON JOHN PHD | Chief Scientific Officer | 1 | $0 | $0 | 2013-09-13 |
| BROOKS JOEL | CFO, Secretary, Treasurer | 1 | $0 | $0 | 2013-09-13 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | F Tax w/h | 2026-10-21 | 2026-10-23 | 19,953 | — | $0 | 54,890 | SEC↗ |
| Lu Timothy K | CEO, Director | F Tax w/h | 2026-10-21 | 2026-10-23 | 157,312 | — | $0 | 482,271 | SEC↗ |
| Lu Timothy K | CEO | F Tax w/h | 2026-03-09 | 2026-03-11 | 80,666 | — | $0 | 639,583 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | F Tax w/h | 2026-03-09 | 2026-03-11 | 10,757 | — | $0 | 74,843 | SEC↗ |
| Lu Timothy K | CEO | F Tax w/h | 2026-02-02 | 2026-02-03 | 4,191 | — | $0 | 720,249 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | F Tax w/h | 2026-02-02 | 2026-02-03 | 1,384 | — | $0 | 85,600 | SEC↗ |
| Baum Bryan Daniel | Director | A Award deriv | 2025-07-18 | 2025-07-21 | 43,900 | — | $0 | 43,900 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 21,950 | — | $0 | 21,950 | SEC↗ |
| Tang Donald F | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 21,950 | — | $0 | 21,950 | SEC↗ |
| COOPERSTONE BRENDA | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 21,950 | — | $0 | 21,950 | SEC↗ |
| Schulz Fran | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 21,950 | — | $0 | 21,950 | SEC↗ |
| Hsiung Feng | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 21,950 | — | $0 | 21,950 | SEC↗ |
| Collins James J. | Director | A Award deriv | 2025-06-25 | 2025-06-27 | 21,950 | — | $0 | 21,950 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | C Conversion deriv | 2025-03-10 | 2025-03-11 | 33 | $2250.00 | $74.3K | 0 | SEC↗ |
| Bayer US Holding LP | 10% Owner | C Conversion deriv | 2025-03-10 | 2025-03-12 | 2,222 | — | $0 | 0 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | C Conversion deriv | 2025-03-10 | 2025-03-12 | 3,333 | — | $0 | 0 | SEC↗ |
| Celadon Partners SPV 24 | 10% Owner | C Conversion deriv | 2025-03-10 | 2025-03-14 | 9,777 | — | $0 | 0 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | C Conversion | 2025-03-10 | 2025-03-11 | 33,000 | $2.25 | $74.3K | 33,000 | SEC↗ |
| Bayer US Holding LP | 10% Owner | C Conversion | 2025-03-10 | 2025-03-12 | 2,222,000 | — | $0 | 2,809,848 | SEC↗ |
| Florence Anthony A. Jr. | 10% Owner | C Conversion | 2025-03-10 | 2025-03-12 | 3,333,000 | — | $0 | 3,775,615 | SEC↗ |
| Celadon Partners SPV 24 | 10% Owner | C Conversion | 2025-03-10 | 2025-03-14 | 9,777,000 | — | $0 | 9,777,000 | SEC↗ |
| Cross John Harry III | Chief Financial Officer | A Award deriv | 2025-03-07 | 2025-03-11 | 174,200 | — | $0 | 174,200 | SEC↗ |
| Hsiung Feng | Director | A Award deriv | 2025-03-07 | 2025-03-11 | 43,900 | — | $0 | 43,900 | SEC↗ |
| COOPERSTONE BRENDA | Director | A Award deriv | 2025-03-07 | 2025-03-11 | 43,900 | — | $0 | 43,900 | SEC↗ |
| Tang Donald F | Director | A Award deriv | 2025-03-07 | 2025-03-11 | 43,900 | — | $0 | 43,900 | SEC↗ |
| Collins James J. | Director | A Award deriv | 2025-03-07 | 2025-03-11 | 43,900 | — | $0 | 43,900 | SEC↗ |
| Schulz Fran | Director | A Award deriv | 2025-03-07 | 2025-03-11 | 43,900 | — | $0 | 43,900 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2025-03-07 | 2025-03-11 | 43,900 | — | $0 | 43,900 | SEC↗ |
| Lu Timothy K | CEO and Interim PFO and PAO | A Award | 2025-03-07 | 2025-03-10 | 642,358 | — | $0 | 724,440 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | A Award | 2025-03-07 | 2025-03-10 | 78,363 | — | $0 | 86,984 | SEC↗ |
| Lu Timothy K | CEO and Interim PFO and PAO | A Award deriv | 2025-03-06 | 2025-03-10 | 1,927,073 | — | $0 | 1,927,073 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | A Award deriv | 2025-03-06 | 2025-03-10 | 235,088 | — | $0 | 235,088 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | S Sale | 2025-02-06 | 2025-02-06 | 182 | $4.37 | $795 | 8,621 | SEC↗ |
| Lu Timothy K | CEO | S Sale | 2025-02-06 | 2025-02-06 | 545 | $4.36 | $2.4K | 82,082 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | S Sale | 2025-02-04 | 2025-02-06 | 1,297 | $4.07 | $5.3K | 8,803 | SEC↗ |
| Lu Timothy K | CEO | S Sale | 2025-02-04 | 2025-02-06 | 3,922 | $4.07 | $16.0K | 82,627 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | A Award deriv | 2024-12-09 | 2024-12-10 | 49,500 | — | $0 | 49,500 | SEC↗ |
| Rajangam Kanya | Pres. & Chief Med. & Dev. Of | A Award deriv | 2024-12-09 | 2024-12-10 | 33 | $2250.00 | $74.3K | 33 | SEC↗ |
| Schulz Fran | Director | A Award deriv | 2024-12-09 | 2024-12-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Tang Donald F | Director | A Award deriv | 2024-12-09 | 2024-12-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Bayer US Holding LP | 10% Owner | P Buy deriv | 2024-12-09 | 2024-12-11 | 3,333,000 | — | $0 | 3,330,000 | SEC↗ |
| Bayer US Holding LP | 10% Owner | P Buy deriv | 2024-12-09 | 2024-12-11 | 2,222 | — | $0 | 2,222 | SEC↗ |
| COOPERSTONE BRENDA | Director | A Award deriv | 2024-07-10 | 2024-07-12 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Collins James J. | Director | A Award deriv | 2024-07-10 | 2024-07-12 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Farokhzad Omid | Director | A Award deriv | 2024-07-10 | 2024-07-12 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2024-07-10 | 2024-07-12 | 62,500 | — | $0 | 62,500 | SEC↗ |
| KNOBELMAN DEBORAH | Chief Financial Officer | A Award deriv | 2024-02-01 | 2024-02-02 | 152,000 | — | $0 | 152,000 | SEC↗ |
| Lu Timothy K | CEO and President | A Award deriv | 2024-02-01 | 2024-02-02 | 459,000 | — | $0 | 459,000 | SEC↗ |
| Rajangam Kanya | Chief Medical & Devt. Office | A Award deriv | 2024-02-01 | 2024-02-02 | 152,000 | — | $0 | 152,000 | SEC↗ |
| KNOBELMAN DEBORAH | Chief Financial Officer | A Award | 2024-02-01 | 2024-02-02 | 101,000 | — | $0 | 131,000 | SEC↗ |
| Lu Timothy K | CEO and President | A Award | 2024-02-01 | 2024-02-02 | 306,000 | — | $0 | 865,496 | SEC↗ |
| Rajangam Kanya | Chief Medical & Devt. Office | A Award | 2024-02-01 | 2024-02-02 | 101,000 | — | $0 | 101,000 | SEC↗ |
| Farokhzad Omid | Director | A Award deriv | 2023-06-16 | 2023-06-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| COOPERSTONE BRENDA | Director | A Award deriv | 2023-06-16 | 2023-06-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Collins James J. | Director | A Award deriv | 2023-06-16 | 2023-06-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Berland Susan D | Director | A Award deriv | 2023-06-16 | 2023-06-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2023-06-16 | 2023-06-21 | 62,500 | — | $0 | 62,500 | SEC↗ |
| Lu Timothy K | CEO and President | A Award deriv | 2023-02-01 | 2023-02-02 | 630,000 | — | $0 | 630,000 | SEC↗ |
| Rajangam Kanya | Chief Medical & Devt. Office | A Award deriv | 2023-02-01 | 2023-02-02 | 130,000 | — | $0 | 130,000 | SEC↗ |
| KNOBELMAN DEBORAH | Chief Financial Officer | A Award deriv | 2023-02-01 | 2023-02-02 | 130,000 | — | $0 | 130,000 | SEC↗ |
| Lee Philip J | Chief Technology Officer | A Award deriv | 2023-02-01 | 2023-02-02 | 195,000 | — | $0 | 195,000 | SEC↗ |
| KNOBELMAN DEBORAH | Chief Financial Officer | A Award deriv | 2022-10-03 | 2022-10-04 | 240,000 | — | $0 | 240,000 | SEC↗ |
| KNOBELMAN DEBORAH | Chief Financial Officer | A Award | 2022-10-03 | 2022-10-04 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Rajangam Kanya | Chief Medical & Devt. Office | A Award deriv | 2022-07-18 | 2022-07-20 | 327,750 | — | $0 | 327,750 | SEC↗ |
| COOPERSTONE BRENDA | Director | A Award deriv | 2022-07-13 | 2022-07-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Epstein David R | Director | A Award deriv | 2022-07-13 | 2022-07-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Berland Susan D | Director | A Award deriv | 2022-07-13 | 2022-07-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Farokhzad Omid | Director | A Award deriv | 2022-07-13 | 2022-07-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Collins James J. | Director | A Award deriv | 2022-07-13 | 2022-07-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Mathers Edward T | Director | A Award deriv | 2022-07-13 | 2022-07-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Dynamics Sponsor LLC | Director, 10% Owner | M Exercise deriv | 2022-06-08 | 2022-06-10 | 5,750,000 | — | $0 | 0 | SEC↗ |
| Farokhzad Omid | Director | M Exercise deriv | 2022-06-08 | 2022-06-10 | 5,750,000 | — | $0 | 0 | SEC↗ |
| Epstein David R | Director | M Exercise deriv | 2022-06-08 | 2022-06-10 | 112,519 | — | $0 | 0 | SEC↗ |
| Dynamics Sponsor LLC | Director, 10% Owner | J Other | 2022-06-08 | 2022-06-10 | 6,465,500 | — | $0 | 0 | SEC↗ |
| Dynamics Sponsor LLC | Director, 10% Owner | M Exercise | 2022-06-08 | 2022-06-10 | 5,750,000 | — | $0 | 6,465,500 | SEC↗ |
| Farokhzad Omid | Director | A Award | 2022-06-08 | 2022-06-10 | 250,000 | $10.00 | $2.50M | 250,000 | SEC↗ |
| Farokhzad Omid | Director | J Other | 2022-06-08 | 2022-06-10 | 4,518,097 | — | $0 | 1,947,403 | SEC↗ |
| Farokhzad Omid | Director | M Exercise | 2022-06-08 | 2022-06-10 | 5,750,000 | — | $0 | 6,465,500 | SEC↗ |
| Epstein David R | Director | A Award | 2022-06-08 | 2022-06-10 | 112,519 | — | $0 | 123,252 | SEC↗ |
| MARTELL RON | Chief Executive Officer | A Award deriv | 2014-06-25 | 2014-06-26 | 400,000 | — | $0 | 400,000 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award deriv | 2014-06-13 | 2014-06-16 | 24,641 | — | $0 | 24,641 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | D To issuer deriv | 2014-06-13 | 2014-06-16 | 24,641 | — | $0 | 0 | SEC↗ |
| SMIDER VAUGHN | See Remarks | A Award deriv | 2014-06-13 | 2014-06-16 | 242,563 | — | $0 | 242,563 | SEC↗ |
| SMIDER VAUGHN | See Remarks | D To issuer deriv | 2014-06-13 | 2014-06-16 | 7,411 | — | $0 | 0 | SEC↗ |
| SMIDER VAUGHN | See Remarks | D To issuer deriv | 2014-06-13 | 2014-06-16 | 242,563 | — | $0 | 7,411 | SEC↗ |
| SMIDER VAUGHN | See Remarks | A Award deriv | 2014-06-13 | 2014-06-16 | 7,411 | — | $0 | 249,974 | SEC↗ |
| Frost Gamma Investments Trust | 10% Owner | A Award deriv | 2014-06-13 | 2014-06-17 | 333,333 | — | $0 | 333,333 | SEC↗ |
| Frost Gamma Investments Trust | 10% Owner | D To issuer deriv | 2014-06-13 | 2014-06-17 | 211,626 | — | $0 | 0 | SEC↗ |
| Frost Gamma Investments Trust | 10% Owner | D To issuer deriv | 2014-06-13 | 2014-06-17 | 333,333 | — | $0 | 0 | SEC↗ |
| Frost Gamma Investments Trust | 10% Owner | A Award deriv | 2014-06-13 | 2014-06-17 | 211,626 | — | $0 | 211,626 | SEC↗ |
| STALDER RUEDI | Director | A Award deriv | 2014-05-16 | 2014-05-20 | 7,500 | — | $0 | 52,405 | SEC↗ |
| Van Hulst Jack | Director | A Award deriv | 2014-05-16 | 2014-05-20 | 7,500 | — | $0 | 43,056 | SEC↗ |
| RIOS MIGUEL DE LOS | VP- Research | A Award deriv | 2014-05-16 | 2014-05-20 | 113,082 | — | $0 | 113,082 | SEC↗ |
| Frost Gamma Investments Trust | Director, 10% Owner | A Award deriv | 2014-05-16 | 2014-05-20 | 233,696 | — | $0 | 567,029 | SEC↗ |
| Frost Gamma Investments Trust | Director, 10% Owner | A Award deriv | 2014-05-16 | 2014-05-20 | 6,927 | — | $0 | 6,927 | SEC↗ |
| Frost Gamma Investments Trust | Director, 10% Owner | A Award deriv | 2014-05-16 | 2014-05-20 | 211,626 | — | $0 | 544,959 | SEC↗ |
| Frost Gamma Investments Trust | Director, 10% Owner | A Award deriv | 2014-05-16 | 2014-05-20 | 11,688 | — | $0 | 11,688 | SEC↗ |
| Frost Gamma Investments Trust | Director, 10% Owner | A Award deriv | 2014-05-16 | 2014-05-20 | 646 | — | $0 | 646 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 1,361 | — | $0 | 1,361 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 76 | — | $0 | 76 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 27,211 | — | $0 | 27,211 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 24,641 | — | $0 | 24,641 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 807 | — | $0 | 807 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 410 | — | $0 | 13,804 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 23 | — | $0 | 762 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 8,185 | — | $0 | 276,047 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 244 | — | $0 | 8,180 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 7,411 | — | $0 | 249,974 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 13,394 | — | $0 | 13,394 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 739 | — | $0 | 739 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 267,862 | — | $0 | 267,862 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 7,936 | — | $0 | 7,936 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award deriv | 2014-05-16 | 2014-05-20 | 242,563 | — | $0 | 242,563 | SEC↗ |
| QUICK THOMAS C | Director | A Award | 2014-05-16 | 2014-05-20 | 5,000 | — | $0 | 13,149 | SEC↗ |
| Isabelle Warren John | Director | A Award | 2014-05-16 | 2014-05-20 | 5,000 | — | $0 | 6,038 | SEC↗ |
| Frost Gamma Investments Trust | Director, 10% Owner | A Award | 2014-05-16 | 2014-05-20 | 896,504 | — | $0 | 1,563,170 | SEC↗ |
| GRAZIANO JAMES JOSEPH | Chief Technology Officer | A Award | 2014-05-16 | 2014-05-20 | 104,386 | — | $0 | 104,386 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award | 2014-05-16 | 2014-05-20 | 31,396 | — | $0 | 1,058,970 | SEC↗ |
| SMIDER VAUGHN | Chief Scientific Officer | A Award | 2014-05-16 | 2014-05-20 | 1,027,574 | — | $0 | 1,058,970 | SEC↗ |
| STALDER RUEDI | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 20,306 | — | $0 | 44,905 | SEC↗ |
| Van Hulst Jack | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 16,788 | — | $0 | 35,556 | SEC↗ |
| FORBES CHRISTOPHER | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 17,464 | — | $0 | 36,406 | SEC↗ |
| RECTOR DAVID | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 21,074 | — | $0 | 41,682 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 21,932 | — | $0 | 54,298 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 21,074 | — | $0 | 40,946 | SEC↗ |
| QUICK THOMAS C | Director | A Award deriv | 2014-05-14 | 2014-05-16 | 10,560 | — | $0 | 26,738 | SEC↗ |
| Browne Leslie J | President and CEO | P Buy | 2013-12-19 | 2013-12-20 | 800 | $4.15 | $3.3K | 1,290 | SEC↗ |
| BROOKS JOEL | CFO, Secretary, Treasurer | A Award deriv | 2013-09-13 | 2013-09-16 | 985,000 | — | $0 | 2,177,200 | SEC↗ |
| Dondero Richard S | VP Research | A Award deriv | 2013-09-13 | 2013-09-16 | 985,000 | — | $0 | 2,360,124 | SEC↗ |
| THOMPSON JOHN PHD | Chief Scientific Officer | A Award deriv | 2013-09-13 | 2013-09-16 | 985,000 | — | $0 | 2,203,276 | SEC↗ |
| RECTOR DAVID | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 371,000 | — | $0 | 2,080,765 | SEC↗ |
| Van Hulst Jack | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 265,000 | — | $0 | 1,876,761 | SEC↗ |
| Browne Leslie J | President and CEO | A Award deriv | 2013-09-13 | 2013-09-16 | 1,723,000 | — | $0 | 4,157,800 | SEC↗ |
| FORBES CHRISTOPHER | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 318,000 | — | $0 | 2,002,193 | SEC↗ |
| STALDER RUEDI | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 265,000 | — | $0 | 2,479,851 | SEC↗ |
| QUICK THOMAS C | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 265,000 | — | $0 | 1,637,763 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 371,000 | — | $0 | 1,992,215 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 530,000 | — | $0 | 3,236,572 | SEC↗ |
| Isabelle Warren John | Director | A Award deriv | 2013-09-13 | 2013-09-16 | 265,000 | — | $0 | 755,000 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2013-09-13 | 2013-09-24 | 530,000 | — | $0 | 3,236,572 | SEC↗ |
| Browne Leslie J | President and CEO | P Buy | 2013-05-20 | 2013-05-21 | 30,000 | $0.04 | $1.2K | 49,000 | SEC↗ |
| FORBES CHRISTOPHER | Director | A Award deriv | 2013-05-17 | 2013-05-20 | 238,372 | — | $0 | 1,684,193 | SEC↗ |
| RECTOR DAVID | Director | A Award deriv | 2013-05-17 | 2013-05-20 | 244,186 | — | $0 | 1,704,765 | SEC↗ |
| STALDER RUEDI | Director | A Award deriv | 2013-05-17 | 2013-05-20 | 296,512 | — | $0 | 2,214,851 | SEC↗ |
| QUICK THOMAS C | Director | A Award deriv | 2013-05-17 | 2013-05-20 | 162,790 | — | $0 | 1,372,763 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2013-05-17 | 2013-05-20 | 139,534 | — | $0 | 1,621,215 | SEC↗ |
| Van Hulst Jack | Director | A Award deriv | 2013-05-17 | 2013-05-20 | 255,814 | — | $0 | 1,611,761 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2013-05-17 | 2013-05-20 | 273,256 | — | $0 | 2,716,572 | SEC↗ |
| Van Hulst Jack | Director | A Award deriv | 2013-02-19 | 2013-02-20 | 71,970 | — | $0 | 1,355,947 | SEC↗ |
| FORBES CHRISTOPHER | Director, 10% Owner | A Award deriv | 2013-02-19 | 2013-02-20 | 89,016 | — | $0 | 1,495,821 | SEC↗ |
| QUICK THOMAS C | Director | A Award deriv | 2013-02-19 | 2013-02-20 | 75,758 | — | $0 | 1,209,973 | SEC↗ |
| Waksal Harlan | Director | A Award deriv | 2013-02-19 | 2013-02-20 | 145,834 | — | $0 | 2,433,316 | SEC↗ |
| RECTOR DAVID | Director | A Award deriv | 2013-02-19 | 2013-02-20 | 96,590 | — | $0 | 1,460,579 | SEC↗ |
| BRACA JOHN N | Director | A Award deriv | 2013-02-19 | 2013-02-20 | 56,818 | — | $0 | 1,481,681 | SEC↗ |
| STALDER RUEDI | Director | A Award deriv | 2013-02-19 | 2013-02-20 | 119,318 | — | $0 | 1,918,339 | SEC↗ |